Skip to content
10-Q

Quarterly Report

BIOMIMETIC THERAPEUTICS, INC.

0001144204-12-059453

← back to feed
Filed
Nov 5, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Nov 1, 2012 28.23M sh
Capex Q3 2012 · Sep 30, 2012 $17.48K
Capex Q3 2012 · Sep 30, 2011 $1.89M
Operating Cash Flow Q3 2012 · Sep 30, 2012 −$16.97M
Operating Cash Flow Q3 2012 · Sep 30, 2011 −$23.41M
Short Term Investments Q3 2012 · Sep 30, 2012 $28.77M
Short Term Investments Q3 2012 · Dec 31, 2011 $42.95M
Cash And Equivalents Q3 2012 · Sep 30, 2012 $15.49M
Cash And Equivalents Q3 2012 · Dec 31, 2011 $18.5M
Cash And Equivalents Q3 2012 · Sep 30, 2011 $21.49M
Cash And Equivalents Q3 2012 · Dec 31, 2010 $11.63M
Stockholders Equity Q3 2012 · Sep 30, 2012 $39.29M
Stockholders Equity Q3 2012 · Dec 31, 2011 $54.01M
Current Liabilities Q3 2012 · Sep 30, 2012 $4.26M
Current Liabilities Q3 2012 · Dec 31, 2011 $6.52M
Total Liabilities Q3 2012 · Sep 30, 2012 $17.8M
Total Liabilities Q3 2012 · Dec 31, 2011 $20.87M
Current Assets Q3 2012 · Sep 30, 2012 $49.5M
Current Assets Q3 2012 · Dec 31, 2011 $66.67M
Total Assets Q3 2012 · Sep 30, 2012 $57.09M
Total Assets Q3 2012 · Dec 31, 2011 $74.89M
Sga Expense Q3 2012 · Sep 30, 2012 $3M
Sga Expense Q3 2012 · Sep 30, 2012 $10.16M
Sga Expense Q3 2012 · Sep 30, 2011 $3.59M
Sga Expense Q3 2012 · Sep 30, 2011 $12.26M
Rd Expense Q3 2012 · Sep 30, 2012 $1.93M
Rd Expense Q3 2012 · Sep 30, 2012 $7.45M
Rd Expense Q3 2012 · Sep 30, 2011 $3.6M
Rd Expense Q3 2012 · Sep 30, 2011 $11.45M
Net Income Q3 2012 · Sep 30, 2012 −$4.6M
Net Income Q3 2012 · Sep 30, 2012 −$17.13M
Net Income Q3 2012 · Sep 30, 2011 −$7.12M
Net Income Q3 2012 · Sep 30, 2011 −$23.32M
Operating Income Q3 2012 · Sep 30, 2012 −$4.61M
Operating Income Q3 2012 · Sep 30, 2012 −$17.19M
Operating Income Q3 2012 · Sep 30, 2011 −$7.14M
Operating Income Q3 2012 · Sep 30, 2011 −$23.4M
Revenue Q3 2012 · Sep 30, 2012 $688.66K
Revenue Q3 2012 · Sep 30, 2012 $1.59M
Revenue Q3 2012 · Sep 30, 2011 $428.63K
Revenue Q3 2012 · Sep 30, 2011 $1.27M